Urinary Biomarkers of Renal Injury KIM-1 and NGAL: Reference Intervals for Healthy Pediatric Population in Sri Lanka

P Mangala C S De Silva1, T D K S C Gunasekara1, S D Gunarathna1

  • 1Department of Zoology, Faculty of Science, University of Ruhuna, Matara 81000, Sri Lanka.

Insights

This study establishes crucial reference intervals for kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) in Sri Lankan children. These findings aid in early detection of renal damage, particularly in areas affected by chronic kidney disease of unexplained etiology (CKDu).

Area of Science:

  • Nephrology
  • Biomarker Discovery
  • Pediatric Research

Background:

  • Emerging renal biomarkers like KIM-1 and NGAL show promise for diagnosing kidney injury.
  • Limited global data exists on reference intervals for these biomarkers in pediatric populations.
  • Sri Lanka faces a high burden of chronic kidney disease of unexplained etiology (CKDu), particularly in children.

Purpose of the Study:

  • To determine reference intervals for urinary KIM-1 and NGAL in a pediatric population in Sri Lanka.
  • To provide essential data for early renal damage screening in at-risk communities.
  • To address the lack of pediatric reference data for emerging renal biomarkers.

Main Methods:

  • Urine samples were collected from 909 children (10-18 years) without prior renal disease in Sri Lanka's dry zone.
  • Urinary KIM-1 and NGAL concentrations were measured using ELISA and normalized to urinary creatinine.
  • Reference intervals were derived using quantile regression, stratified by age and gender.

Main Results:

  • Median reference intervals for urinary KIM-1 ranged from 0.081-0.426 ng/mg Cr (males) and 0.078-0.508 ng/mg Cr (females).
  • Median reference intervals for urinary NGAL ranged from 2.966-4.850 ng/mg Cr (males) and 2.085-3.496 ng/mg Cr (females).
  • Biomarker levels showed weak correlations with age, gender, ACR, and BMI.

Conclusions:

  • This study provides the first pediatric reference intervals for KIM-1 and NGAL in Sri Lanka.
  • These reference intervals are vital for facilitating early detection of renal damage.
  • The findings are particularly relevant for screening in rural communities affected by CKDu.

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
151
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
436
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
43
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44